Skip to main content

CORRECTION article

Front. Neurol., 22 March 2024
Sec. Neurological Biomarkers
Volume 15 - 2024 | https://doi.org/10.3389/fneur.2024.1399344

Corrigendum: Clinical value of serum complement component 1q levels in the prognostic analysis of aneurysmal subarachnoid hemorrhage: a prospective cohort study

This article is a correction to:

  1. Clinical value of serum complement component 1q levels in the prognostic analysis of aneurysmal subarachnoid hemorrhage: a prospective cohort study

    1. Read original article
\r\nLinjie Wang&#x;Linjie Wang1†Haotian Zhou&#x;Haotian Zhou1†Wenhao ZhengWenhao Zheng2Heng WangHeng Wang1Zheng WangZheng Wang1Xiaoqiao DongXiaoqiao Dong2Quan Du Quan Du2*
  • 1The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China
  • 2Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China

A corrigendum on
Clinical value of serum complement component 1q levels in the prognostic analysis of aneurysmal subarachnoid hemorrhage: a prospective cohort study

by Wang, L., Zhou, H., Zheng, W., Wang, H., Wang, Z., Dong, X., and Du, Q. (2024). Front. Neurol. 15:1341731. doi: 10.3389/fneur.2024.13417311

In the published article, there was an error in affiliation(s) [1,2]. Instead of

1 The Fourth Clinical Medical College, Zhejiang Chinese Medical University, Hangzhou, China

2 Department of Neurosurgery, The First People's Hospital of Hangzhou, Zhejiang University School of Medicine, Hangzhou, China

It should be

1 The Fourth School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, China

2 Department of Neurosurgery, Affiliated Hangzhou First People's Hospital, School of Medicine, Westlake University, Hangzhou, China

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Keywords: aneurysmal subarachnoid Hemorrhage, Complement component 1q, prognosis, delayed cerebral ischemia, biomarker

Citation: Wang L, Zhou H, Zheng W, Wang H, Wang Z, Dong X and Du Q (2024) Corrigendum: Clinical value of serum complement component 1q levels in the prognostic analysis of aneurysmal subarachnoid hemorrhage: a prospective cohort study. Front. Neurol. 15:1399344. doi: 10.3389/fneur.2024.1399344

Received: 11 March 2024; Accepted: 13 March 2024;
Published: 22 March 2024.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2024 Wang, Zhou, Zheng, Wang, Wang, Dong and Du. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Quan Du, duquan76@163.com

†These authors have contributed equally to this work and share first authorship

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.